| 1994 |
SYT3 (Syt3) was identified as a third member of the synaptotagmin family in mouse brain, retaining the characteristic five-domain structure (transmembrane region plus two C2 domains) of other synaptotagmins but with only ~45% amino acid identity to Syt1/Syt2 in the C2 domain. Syt3 is expressed in many regions of the nervous system but not in extraneural tissues, and in PC12 cells it is coexpressed with Syt1 at higher abundance, suggesting individual neurons may express specific synaptotagmin combinations. |
cDNA cloning, Northern blot, immunohistochemistry, in situ hybridization |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
8058779
|
| 1995 |
The first C2 domain of Syt III (but not the C2 domain of Syt IV, VI, or VIII) binds phospholipids in a Ca2+-dependent manner with EC50 = 3–6 µM, similar to Syt I and II. Syt III also binds syntaxin in a Ca2+-dependent manner, but with a lower Ca2+ concentration dependence (<10 µM) than Syt I, II, and V (>200 µM), and all synaptotagmins tested bind clathrin-AP2 with high affinity (Kd = 0.1–1.0 nM). |
In vitro phospholipid-binding assay, Ca2+-dependent syntaxin binding assay, clathrin-AP2 binding assay |
Nature |
High |
7791877
|
| 1999 |
Syt III forms beta-mercaptoethanol-sensitive homodimers and heterodimers with Syt V, VI, and X via three conserved N-terminal cysteine residues (C10, C21, C33 in mouse Syt III). Site-directed mutagenesis showed that the first cysteine (C10) is essential for stable homodimer formation of Syt III, V, and VI, and for heterodimer formation among Syt III, V, VI, and X. Native Syt III from mouse brain also forms these disulfide-linked homodimers. |
Site-directed mutagenesis, co-immunoprecipitation, SDS-PAGE under reducing/non-reducing conditions, native brain protein analysis |
The Journal of biological chemistry |
High |
10531343
|
| 2007 |
E-Syt3 (extended synaptotagmin-3) is an ER-resident transmembrane protein with three C-terminal C2 domains. Its C2C domain (the most C-terminal C2 domain) functions as a targeting motif directing E-Syt3 to the plasma membrane independently of its transmembrane region. E-Syt2 and E-Syt3 localize to the plasma membrane in transfected cells, unlike E-Syt1 which localizes to intracellular membranes. |
Transfection of myc-tagged constructs, immunofluorescence microscopy, domain deletion analysis |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
17360437
|
| 2010 |
The crystal structure of Ca2+-bound Syt3 in complex with the SNARE complex was determined and revealed that the Ca2+-binding loops of Syt3 point away from the SNARE complex, suggesting they may interact with the same membrane. This loop arrangement is similar to that inferred from smFRET-derived models of the Syt1-SNARE complex, supporting a conserved mechanism by which synaptotagmin-SNARE interaction aids Ca2+-triggered fusion. |
X-ray crystallography (crystal structure of SNARE-induced Ca2+-bound Syt3), single-molecule FRET |
Nature structural & molecular biology |
High |
20173763
|
| 2011 |
A lipid-binding screen using the C2AB fragment of Syt3 revealed Ca2+-independent lipid interactions mediated via a lysine-rich region of the C2B domain and Ca2+-dependent interactions via the Ca2+-binding loops, consistent with a conserved lipid-binding mechanism shared with Syt1. |
Lipid binding screen (protein-lipid overlay and liposome binding assays) with recombinant C2AB fragments, mass spectrometry |
Biochemistry |
Medium |
21928778
|
| 2013 |
E-Syt2 and E-Syt3 function as ER-PM tethers through C2 domain-dependent interactions with the plasma membrane that require PI(4,5)P2. E-Syts form heteromeric complexes with each other, and through this heterodimerization, E-Syt1 (which also requires elevated cytosolic Ca2+) confers Ca2+ regulation to ER-PM contact formation. E-Syt-dependent contacts are functionally distinct from STIM1/Orai1-mediated contacts and are not required for store-operated Ca2+ entry. |
Co-immunoprecipitation, fluorescence microscopy, PI(4,5)P2 manipulation (pharmacological and genetic), Ca2+ imaging, TIRF microscopy |
Cell |
High |
23791178
|
| 2016 |
E-Syt3 (along with E-Syt1 and E-Syt2) transfers glycerolipids between bilayers in vitro in a Ca2+-dependent manner requiring their SMP domain. Cells lacking all E-Syts show enhanced and sustained accumulation of plasma membrane diacylglycerol following PLC activation (PtdIns(4,5)P2 hydrolysis), demonstrating that E-Syts participate in homeostatic control of PM lipid composition by transferring diacylglycerol from the PM to the ER for metabolic recycling. |
In vitro lipid transfer assay, genome-edited E-Syt knockout cells, diacylglycerol imaging (DAG biosensor), rescue experiments with SMP-domain mutants |
Nature cell biology |
High |
27065097
|
| 2016 |
Combined inactivation of all three E-Syt genes (E-Syt1, 2, and 3) in mice does not affect viability, fertility, or development under laboratory conditions, but induces compensatory upregulation of Orp5/8, Orai1, STIM1, and TMEM110 genes encoding other ER-PM junction proteins. |
Triple knockout mouse generation (insertion/deletion mutations), phenotypic analysis, gene expression analysis |
Cell cycle (Georgetown, Tex.) |
Medium |
27399837
|
| 2017 |
RASSF4 regulates the ER-PM tethering function of E-Syt2 and E-Syt3 by controlling steady-state PM PI(4,5)P2 levels through ARF6-dependent regulation of type I PIP5Ks. RASSF4 knockdown reduces PM PI(4,5)P2, which is required for E-Syt2/3 localization at ER-PM junctions. |
siRNA knockdown, PI(4,5)P2 biosensor imaging, TIRF microscopy, RASSF4-ARF6 interaction analysis |
The Journal of cell biology |
Medium |
28600435
|
| 2006 |
SYT3 is the only synaptotagmin expressed in T cells. SYT3 localizes predominantly to multivesicular bodies (not the plasma membrane) where it colocalizes with CXCR4. Knockdown of SYT3 by antisense mRNA or blockade by the isolated C2B domain (which impairs oligomerization) inhibits CXCR4 recycling back to the cell surface, reduces surface CXCR4 levels, and consequently inhibits CXCL12-induced T cell migration and actin polymerization. Overexpression of CXCR4 rescues migration, confirming the mechanism is through receptor recycling. |
Antisense mRNA knockdown, C2B domain overexpression, immunofluorescence microscopy, flow cytometry (surface CXCR4), chemotaxis assay, actin polymerization assay |
Journal of cell science |
Medium |
17179206
|
| 2018 |
Syt3 localizes to postsynaptic endocytic zones in neurons and removes AMPA receptors (specifically GluA2-containing) from synaptic plasma membranes in a Ca2+-dependent manner in response to stimulation. Syt3 knockout abolishes AMPA receptor internalization, long-term depression (LTD), and decay of long-term potentiation (LTP). Disrupting the Syt3:GluA2 interaction using a TAT-GluA2-3Y peptide mimics the Syt3 KO phenotype (lack of LTP decay and lack of forgetting in spatial memory tasks), and these effects are occluded in the Syt3 KO, confirming direct mechanistic linkage. |
Syt3 knockout mice, immunofluorescence localization, AMPA receptor internalization assay, LTD and LTP electrophysiology, TAT-GluA2-3Y peptide competition, Morris water maze and spatial memory tasks |
Science (New York, N.Y.) |
High |
30545844
|
| 2020 |
Hypothalamic E-Syt3 (extended synaptotagmin-3) contributes to diet-induced obesity. Whole-body or POMC neuron-specific ablation of E-Syt3 ameliorates diet-induced obesity, glucose intolerance, and dyslipidemia. Mechanistically, E-Syt3 ablation leads to increased processing of POMC to α-MSH, increased PKC and AP-1 activities, and enhanced expression of prohormone convertases. Conversely, E-Syt3 overexpression in the arcuate nucleus promotes food intake and impairs energy expenditure. |
Conditional KO (whole-body and POMC-neuron-specific), AAV-mediated overexpression, Western blot, ELISA, metabolic phenotyping, kinase activity assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
32747560
|
| 2021 |
In differentiating adipocytes, E-Syt3 undergoes proteolytic cleavage of its C-terminal C2C domain by a proteasome-dependent multi-step mechanism. Truncated E-Syt3ΔC2C and endogenous E-Syt3 localize to a specialized ER cisterna (termed the 'primordial cisterna') that serves as the birth site of lipid droplets. Knockdown of E-Syt3 inhibits lipid droplet biogenesis in adipocytes. |
Confocal microscopy, live-cell time-lapse imaging, proteasome inhibition, siRNA knockdown, electron microscopy, 3D electron tomography |
Traffic (Copenhagen, Denmark) |
Medium |
34693607
|
| 2023 |
Syt3 is upregulated in the penumbra after ischemia/reperfusion injury. Mechanistically, I/R injury augments Syt3-GluA2 interactions, decreases GluA2 surface expression, and promotes formation of Ca2+-permeable AMPA receptors (CP-AMPARs). Syt3 knockout mice are resistant to cerebral ischemia due to high surface GluA2 and low CP-AMPAR levels. Disrupting Syt3-GluA2 binding via TAT-GluA2-3Y peptide promotes recovery from neurological impairments. |
Syt3 KO mice, siRNA knockdown/overexpression, co-immunoprecipitation (Syt3-GluA2), surface biotinylation assay, TAT-GluA2-3Y peptide, MCAO model, behavioral testing |
Cell reports |
High |
36892998
|
| 2025 |
E-Syt3 controls epithelial ion transport by transferring phosphatidylserine (PtdSer) away from ER/PM junction nanodomains, acting antagonistically to ORP5 (which supplies PtdSer). Removal of PtdSer from junctions by E-Syt3 dissociates the cAMP signaling complex, preventing CFTR chloride channel activation and blocking NBCe1-B activation by IRBIT. The C2C domain of E-Syt3 restricts its localization to ER/PM junctions, and lipid transfer activity requires the SMP domain. E-Syt3 depletion in mice improves chloride flux and fluid secretion in salivary glands and pancreatic ducts. |
SiRNA knockdown, domain deletion mutants, PtdSer biosensor, co-immunoprecipitation, electrophysiology (CFTR and NBCe1-B currents), mouse gland secretion assays, in vitro lipid transfer |
The EMBO journal |
High |
40425857
|
| 2024 |
In zebrafish Mauthner cells, syt3 (ortholog of mammalian SYT3) negatively regulates axon regeneration after spinal cord injury, and this suppression depends on Ca2+ binding by Syt3. MicroRNA-2184 promotes axon regeneration by repressing syt3 expression. Pharmacological stimulation of the cAMP/PKA pathway suggests changes in the readily releasable pool may underlie the Syt3-dependent suppression of regeneration. |
Single M-cell miR-2184 overexpression/sponge silencing, syt3 knockdown/overexpression in zebrafish, Ca2+-binding mutant analysis, cAMP/PKA pathway pharmacology, axon regeneration imaging |
Journal of genetics and genomics |
Medium |
38582297
|
| 2025 |
Syt3 knockout mice exposed to neonatal sevoflurane show exacerbated cognitive impairment, increased neuroinflammation (IL-1β, TNF-α, MCP-1), and increased anxiety-like behavior compared to WT mice. Conversely, CRISPR-mediated Syt3 overexpression in WT mice mitigates sevoflurane-induced cognitive deficits and neuroinflammation. Sevoflurane exposure itself reduces hippocampal Syt3 protein levels in WT mice. |
Syt3 KO mice, CRISPR activation overexpression, Western blot/ELISA for Syt3 and inflammatory markers, object location memory, novel object recognition, elevated plus maze |
ACS chemical neuroscience |
Medium |
40890917
|
| 2026 |
In EPN neurons projecting to the lateral habenula, Syt3 is highly expressed and selectively co-localizes with VGAT (GABAergic vesicle marker) rather than VGLUT2, and antisense oligonucleotide knockdown of Syt3 increases mIPSC frequency (quantal GABA release probability) without affecting glutamate release, establishing Syt3 as the predominant Ca2+ sensor for GABAergic vesicle fusion at these dual-transmitter terminals. |
Confocal 3D reconstruction, antisense oligonucleotide knockdown, whole-cell patch-clamp electrophysiology (mEPSC and mIPSC recording) |
bioRxivpreprint |
Medium |
41959127
|